Sarcopenia is an age‐related disease and is often accompanied by other diseases. Now,
many studies have shown that cardiovascular diseases (CVDs) may raise the incidence rate …

Despite strong scientific evidence supporting the benefits of regular exercise for the
prevention and management of cardiovascular disease (CVD), physical inactivity is highly …

Modifications of lean mass are a frequent critical determinant in the pathophysiology and
progression of heart failure (HF). Sarcopenia may be considered one of the most important …

Aims Sarcopenia has been found to be frequently associated with co‐morbidity among
patients with heart failure (HF). However, there remain insufficient data to accurately …

Sarcopenia, the lowered skeletal muscle mass, weakened skeletal muscle strength, and
reduced physical performance with aging, is a component of frailty and high-risk factor for …

Background Skeletal muscle wasting is an extremely common feature in patients with heart
failure, affecting approximately 20% of ambulatory patients with even higher values during …

Sarcopenia is an age-related geriatric syndrome that is characterized by a progressive loss
of muscle mass, strength and function. Chronic heart failure (CHF), the final stage of various …

Aims Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex
multisystem disease. Evidence for disturbed vascular regulation comes from various studies …

Background Frailty is strongly associated with adverse cardiovascular outcomes; however,
the underlying pathophysiological processes are largely unknown. Vascular endothelial …

In an ageing society, the importance of maintaining healthy life expectancy has been
emphasized. As a result of age-related decline in functional reserve, frailty is a state of …